Key result
Lower cerebrovascular reactivity links to 1-year SVD progression on MRI without affecting clinical outcomes.
Why the study?
Does baseline cerebrovascular reactivity predict 1-year progression of imaging and clinical outcomes in patients with cerebral small vessel disease?
Cohort
Does baseline cerebrovascular reactivity predict 1-year progression of imaging and clinical outcomes in patients with cerebral small vessel disease?
Answers are grounded in this paper and cite their sources.
Lower baseline cerebrovascular reactivity in patients with cerebral small vessel disease predicts 1-year progression of white matter hyperintensities and perivascular space volumes, suggesting its utility as an imaging biomarker.
BACKGROUND AND OBJECTIVES: In patients with cerebral small vessel disease (SVD), impaired cerebrovascular reactivity (CVR) is related to worse concurrent SVD burden, but less is known about cerebrovascular reactivity and long-term SVD lesion progression and clinical outcomes. We investigated associations between cerebrovascular reactivity and 1-year progression of SVD features and clinical outcomes. METHODS: in subcortical gray matter, normal-appearing white matter, and white matter hyperintensities (WMH). At baseline and 1 year, we quantified SVD MRI features, incident infarcts, assessed stroke severity (NIH Stroke Scale), recurrent stroke, functional outcome (modified Rankin Scale), and cognition (Montreal Cognitive Assessment). We performed linear and logistic regressions adjusted for age, sex, and vascular risk factors, reporting the regression coefficients and odds ratios with 95% CIs. RESULTS: (%ROIV) per %/mm Hg), with a similar trend in WMH. CVR was not associated with clinical outcomes at 1 year. DISCUSSION: Lower baseline cerebrovascular reactivity predicted an increase in WMH and perivascular space volumes after 1 year. CVR should be considered in SVD future research and intervention studies.
No takes yet. Share an insight, caveat, or question.
Sleight et al. (2024) conducted a cohort in cerebral small vessel disease (SVD). cerebrovascular reactivity (CVR) was evaluated on 1-year progression of SVD features and clinical outcomes. Lower baseline cerebrovascular reactivity predicted an increase in white matter hyperintensities and perivascular space volumes after 1 year, but was not associated with clinical outcomes.
Synapse has enriched 10 related papers. Consider them for comparative context: